Evidence map›Paper›PMID 22591159›Full record

ArticleChemical research in toxicology2012

Cys34 adducts of reactive oxygen species in human serum albumin.

Hasmik Grigoryan, He Li, Anthony T Iavarone, Evan R Williams, Stephen M Rappaport

Open access · greenAbstract read
In one paragraph

Article in Chemical research in toxicology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Use of Human Serum Albumin CysAntioxidants (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Albumin Is a Component of the Esterase Status of Human Blood Plasma.International journal of molecular sciences · 2023
    Article
  9. Article
  10. Esterase Activity of Serum Albumin Studied byInternational journal of molecular sciences · 2021
    Article
  11. Review
  12. Metabolism and biomarkers of heterocyclic aromatic amines in humans.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hasmik GrigoryanCenter for Exposure Biology, School of Public Health and College of Chemistry, University of California, 50 University Hall, Berkeley, CA 94720-7356, USA.
He Li
Anthony T Iavarone
Evan R Williams
Stephen M Rappaport
University of California, Berkeley · USQB3 · US

Funding

PROTEIN ADDUCTS AS MOLECULAR SIGNATURES OF CARCINOGEN DOSEU54ES016115 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI RAPPAPORT, STEPHEN MORRIS · 2007 to 2011
$5.3M
NIEHS NIH HHS U54 ES016115NIEHS NIH HHS U54ES016115
6 · The paper itself

Abstract

Long-term exposures to reactive oxygen species (ROS) have been linked to scores of chronic diseases. This has motivated interest in oxidation products of the only free cysteine residue (Cys34) of human serum albumin (HSA) as possible biomarkers of ROS exposure. However, Cys34 oxidation products have not been detected in human serum or plasma. Using liquid chromatography-high resolution tandem mass spectrometry, we report accurate masses and molecular compositions of Cys34 oxidation products in the 2432 Da peptide resulting from tryptic digestion of HSA. Peptides containing the expected sulfinic (Cys-SO(2)H) and sulfonic (Cys-SO(3)H) acids, as well as an adduct representing addition of one oxygen atom and loss of two hydrogen atoms, were detected in four archived samples of human plasma and one fresh sample of human serum. We speculate that this latter adduct is a sulfinamide formed by intramolecular reaction between either the Cys34 sulfenic acid (Cys-SOH) or sulfinic acid (Cys-SO(2)H) and the adjacent glutamine residue (Gln33). All three Cys34 adducts were measured in the five human samples with levels decreasing in the order sulfinic acid > (proposed) sulfinamide > sulfonic acid. Parallel measurements of a negative control detected only small amounts of the Cys34 sulfonic acid and the (proposed) sulfinamide and did not detect the sulfinic acid.

Indexed as

Chromatography, High Pressure LiquidCysteineHumansOxidation-ReductionPeptidesReactive Oxygen SpeciesSerum AlbuminSulfenic AcidsSulfinic AcidsSulfonic AcidsTandem Mass SpectrometryTrypsinCysteinePeptidesReactive Oxygen SpeciesSerum AlbuminSulfenic AcidsSulfinic AcidsSulfonic AcidsTrypsin

Identifiers

PMID22591159
PMCPMC4763613
OpenAlexW2041158708

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.